In Brief: DEA and Ma Huang
This article was originally published in The Tan Sheet
Executive Summary
DEA and Ma Huang: Drug Enforcement Administration says it is in the process of determining what types of Ma Huang products are on the market as well as gathering import volume and distribution route data for Ma Huang products. DEA expects to meet with FDA to discuss its findings later this year. FDA and DEA met on Dec. 27, 1994 to discuss whether provisions of the Domestic Chemical Diversion and Trafficking Act of 1993 should be applied to certain ephedra-containing dietary supplements due to concerns that Ma Huang extracts may be used in the production of controlled substances ("The Tan Sheet" Dec. 19, 1994, p. 7)...